IMMUNITYBIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $120.7M | $75.8M |
| FY2020 | — | $-119.8M | $34.9M |
| FY2021 | — | $-242.2M | $181.1M |
| FY2022 | — | $-447.3M | $104.6M |
| FY2023 | — | $-587.0M | $265.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $120.7M | $75.8M |
| FY2020 | — | $-119.8M | $34.9M |
| FY2021 | — | $-242.2M | $181.1M |
| FY2022 | — | $-447.3M | $104.6M |
| FY2023 | — | $-587.0M | $265.5M |